Soleus Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-386,000	Closed	-$4.58M	–	102
2024 Q1	$4.58M	Buy	+386,000	New	+$4.58M	0.34%	65